These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee. Bonelli L Endoscopy; 1993 Nov; 25(9):652-4. PubMed ID: 8119225 [No Abstract] [Full Text] [Related]
45. [Mechanism of photodynamic therapy]. Takemura T; Nakajima S; Sakata I Gan To Kagaku Ryoho; 1996 Jan; 23(1):16-21. PubMed ID: 8546463 [TBL] [Abstract][Full Text] [Related]
46. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. O'Connor JB; Falk GW; Richter JE Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525 [TBL] [Abstract][Full Text] [Related]
47. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Thrift AP Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368 [TBL] [Abstract][Full Text] [Related]
48. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Buttar NS; Wang KK; Lutzke LS; Krishnadath KK; Anderson MA Gastrointest Endosc; 2001 Dec; 54(6):682-8. PubMed ID: 11726842 [TBL] [Abstract][Full Text] [Related]
49. [Epidemiology of Barrett's esophagus--comparison of Japan and the West]. Hanai M; Kusano M; Kawamura O; Shimoyama Y; Maeda M Nihon Rinsho; 2005 Aug; 63(8):1333-9. PubMed ID: 16101218 [TBL] [Abstract][Full Text] [Related]
50. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ; Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200 [TBL] [Abstract][Full Text] [Related]
51. Barrett's esophagus and risk of esophageal adenocarcinoma. Cossentino MJ; Wong RK Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412 [TBL] [Abstract][Full Text] [Related]
52. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Jankowski JA; Provenzale D; Moayyedi P Gastroenterology; 2002 Feb; 122(2):588-90. PubMed ID: 11845805 [No Abstract] [Full Text] [Related]
53. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX]. Ortner M; Lochs H Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692 [No Abstract] [Full Text] [Related]
54. Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. Siersema PD Gastrointest Endosc; 2005 Oct; 62(4):503-7. PubMed ID: 16185961 [No Abstract] [Full Text] [Related]
55. Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma. Upton MP; Nishioka NS; Ransil BJ; Rosenberg SJ; Puricelli WP; Zwas FR; Shields HM Dig Dis Sci; 2006 Oct; 51(10):1783-90. PubMed ID: 16967312 [TBL] [Abstract][Full Text] [Related]
56. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Cen P; Correa AM; Lee JH; Maru D; Anandasabapathy S; Liao Z; Hofstetter WL; Swisher SG; Komaki R; Ross WA; Vaporciyan A; Ajani JA Dis Esophagus; 2009; 22(1):32-41. PubMed ID: 19021684 [TBL] [Abstract][Full Text] [Related]